Ultralarge complexes formed with the various heparin formulations
PHR . | 1.7:1 . | 1.4:1 . | 1:1 . | 0.7:1 . | 1:2 . | 1:4 . | 1:6 . | 1:9 . |
|---|---|---|---|---|---|---|---|---|
| UHF | 14.8 | 23.0 | 29.5 | 10.1 | 0 | 0 | 0 | — |
| Enoxaprin 4.5 kDa | — | — | 3.3 | 14.6 | 18.4 | 4.0 | — | — |
| LMWH 3-4 kDa | — | 3.4 | 3.7 | 3.3 | 3.7 | 5.3 | 7.5 | 4.3 |
| Fondaparinux sodium pentasaccharide | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PHR . | 1.7:1 . | 1.4:1 . | 1:1 . | 0.7:1 . | 1:2 . | 1:4 . | 1:6 . | 1:9 . |
|---|---|---|---|---|---|---|---|---|
| UHF | 14.8 | 23.0 | 29.5 | 10.1 | 0 | 0 | 0 | — |
| Enoxaprin 4.5 kDa | — | — | 3.3 | 14.6 | 18.4 | 4.0 | — | — |
| LMWH 3-4 kDa | — | 3.4 | 3.7 | 3.3 | 3.7 | 5.3 | 7.5 | 4.3 |
| Fondaparinux sodium pentasaccharide | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Proportion of PF4 found as ULCs was calculated as the area below the ULC peak (9-13 min) divided by area below whole curve × 100.
— indicates not tested.